Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1992

Primary Completion Date

June 30, 1994

Study Completion Date

June 30, 1994

Conditions
Anemia, Sickle CellHematologic DiseasesHemoglobinopathies
Interventions
DRUG

hydroxyurea

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000586 - Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) | Biotech Hunter | Biotech Hunter